About the Speakers:
- Erik Larsen, PhD, Senior Vice President, Clinical Development & Customer Success at Sonde Health
- Erik leads clinical data generation and development trials across the Sonde portfolio. He also ensures the successful implementation and growth of Sonde products with partners. His career spans research and management from several leading technology and research organizations. Erik most recently served as head of Translational Medicine at Decibel Therapeutics, where as an early employee, he built and led a team that conducted clinical research programs to support pharmaceutical interventions for treating hearing loss. Before Decibel, Erik was an Associate Principal at McKinsey & Co, where he served clients in pharmaceuticals, biotech and med tech on operations strategy, implementation and transformations. While at McKinsey, Erik led a collaboration with GS1 on research to quantify the business case and public health impact of adopting global standards in the healthcare supply chain. The recommendations were endorsed by dozens of leading healthcare organizations. Erik started his professional career as a research scientist at Philips and the University of Illinois at Urbana-Champaign, where he developed signal processing algorithms for audio, acoustics, and sound reproduction.
- Jennifer Stamps, PhD, Director of Research at Rendever
- Jennifer J. Stamps, PhD is a clinical neuroscientist and the Director of Research at Rendever, a virtual reality company pioneering immersive solutions to improve healthspan. Known for her work in early diagnostics of Alzheimer’s, she brings over 15 years of experience in behavioral neurology and sensory neuroscience to create evidence-based technologies that prevent functional decline, improve the care of those already living with dementia, and support care partners. At Rendever, Dr. Stamps leads NIH-funded clinical trials and collaborative research partnerships with academic, healthcare, and community organizations to evaluate how their VR-based social engagement and fitness platforms can mitigate social isolation and extend independence for older adults. She mentors emerging scientists, advises on age tech, and continues to champion the integration of VR in home, community, and healthcare settings as a non-pharmacological treatment for pain, mental health, and memory loss, and to foster connection, purpose, and joy in later life.
- Michael Milburn, PhD, Founder & Chief Scientific Officer at Impairment Science Inc.
- Michael Milburn is the Founder and Chief Science Officer at Impairment Science, Inc., a position held since April 2016. Prior to this, Michael served as a Professor at UMass/Boston for 40 years with a specialty in research methods, measurement, and statistics. Michael received a Ph.D. in Social Psychology with a focus on Quantitative Methods from Harvard University, and an A.B. in Psychology from Stanford University. His unique set of skills enabled him to develop the Druid app in 2016 and launch a company in 2018 to commercialize the technology. The Druid app allows users to assess the level of their cognitive and motor impairment – their improvement, stability, or decline – due to any cause, including marijuana, alcohol, opioids, other drugs, prescription medicines, fatigue, illness, chronic condition, or injury.